Videos

Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses some red flags that may appear when a patient presents a controlled substance prescription.

Lindsay Bebout, student at University of Oklahoma Tulsa College of Pharmacy, discusses why she decided to go to pharmacy school.

Lindsay Bebout, student at University of Oklahoma Tulsa College of Pharmacy, discusses what kind of role business and ownership play in pharmacy.

Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses pharmacists can distinguish prescriptions that are being issued for legitimate medical purposes from those that are not.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how health-system pharmacists can foster antimicrobial stewardship during care transitions.

Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how the new regulatory requirements for controlled substances are changing pharmacists' daily practice.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses which pipeline antimicrobials are addressing resistant bacteria threats.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, answers the question, "Do any pipeline antimicrobials have new mechanisms of action?"

Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how new regulatory requirements have affected controlled dangerous substance dispensing.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new agents are helping address Clostridium difficile-associated diarrhea concerns.

Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how the DEA has held pharmacists accountable for failing to verify controlled substance prescriptions for a legitimate medical purpose.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developments in contracting that specialty pharmacies need to be aware of.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses the advantages of having pharmacists on the antimicrobial stewardship team.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses new antimicrobials he finds most interesting.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, describes the level of antimicrobial stewardship activities in current practice.

Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how generic immunosuppressive medications change the pharmacist's role.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new antimicrobial options could change existing care and affect stewardship programs.

Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how the transplant pharmacist's role is evolving.

Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how generic immunosuppressive medications benefit patients and payers.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how antimicrobial stewardship activities can improve.

Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment.

Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains the transplant pharmacist's role in reducing patient readmissions.

J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses the areas of antimicrobial stewardship efforts that should be more concentrated.

Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains why there's a need to standardize transplant evaluation procedures.

Thomas Morrow, MD, chief medical officer at Next IT, discusses the various difficulties faced by patients when they begin a specialty therapy regimen.

Jason Gallagher, PharmD, FCCP, a clinical pharmacy specialist of infectious diseases at Temple University, discusses how drug-resistant pathogen prevalence varies by region.

Joseph Saseen, PharmD, from the Department of Clinical Pharmacy at the University of Colorado School of Pharmacy, discusses which characteristics of first-line therapies pertinent for newly diagnosed hypertension patients.

Jason Gallagher, PharmD, FCCP, a clinical pharmacy specialist of infectious diseases at Temple University, discusses measures pharmacists can take to reduce and prevent antimicrobial resistant infections.

Joseph Saseen, PharmD, from the Department of Clinical Pharmacy at the University of Colorado School of Pharmacy, discusses key points in the new guidelines for high cholesterol management.

Joseph Saseen, PharmD, from the Department of Clinical Pharmacy at the University of Colorado School of Pharmacy, discusses which points in the new hypertension guidelines are particularly different from the previous guidelines.